Prelude Capital Management, LLC Moderna, Inc. Put Options Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $746,114 - $1.39 Million	-5,900 Reduced 66.29%	3,000 $517,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $338,730 - $552,765	-1,500 Reduced 14.42%	8,900 $2.26 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $2.09 Million - $4.55 Million	9,400 Added 940.0%	10,400 $4 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $25,982 - $46,996	-200 Reduced 16.67%	1,000 $235,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $54,340 - $94,850	-1,000 Reduced 45.45%	1,200 $85,000
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $44,505 - $120,000	1,500 Added 214.29%	2,200 $141,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $12,446 - $22,106	700 New	700 $21,000

928

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.